Reagent Application for β-Hydroxybutyrate 21FS Assay Now Available for Roche cobas® Clinical Chemistry Systems
SAN ANTONIO, Texas, October 16, 2020 – Vidan Diagnostics, LLC today announced that it has validated the reagent application for its β-Hydroxybutyrate 21FS Next Generation Reagent to be used on the Roche cobas® clinical chemistry systems. Roche is a market leader within the in-vitro diagnostics, (IVD) market with more than 50 years’ experience in developing Clinical Chemistry reagents and instrumentation. Beta-Hydroxybutyrate (BHB) is an important marker when used in conjunction with clinical findings and other laboratory tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA).
Roche cobas® Reagent Application for Beta-Hydroxybutyrate
Vidan Diagnostics’ β-Hydroxybutyrate 21FS assay offers 70 days calibration and onboard stability and a linear range up to 6.0 mmol/L. “Many leading U.S. hospital laboratories have transitioned from our competitor’s beta-hydroxybutyrate reagent to ours”, said Gilbert Mejia, CEO of Vidan Diagnostics. Our Roche cobas® customers have come to realize the benefits of our next generation beta-hydroxybutyrate reagent that include precision, accuracy, and a significant cost savings”, Mejia added.
Beta-hydroxybutyrate is the predominate ketone body produced during Diabetic Ketoacidosis, (DKA) It’s relative proportion in the blood, (78%) is greater than the other two ketones, acetoacetate, (20%) and acetone, (2%) and is therefore the best indicator of DKA. DKA is a serious condition that can lead to diabetic coma or even death.
Founded in 2015, Vidan Diagnostics LLC is a supplier of medical diagnostic products. It is focused on medical devices and reagents used for diagnosing and monitoring patients with conditions of diabetes, sepsis, anemia, heart disease and stroke. Vidan Diagnostics is dedicated to delivering proven and innovative products to all people in all places, in all aspects and stages of life with integrity and reliability. The company is headquartered in San Antonio, Texas.